The Osteoarthritis Therapeutics Market was valued at USD 8.65 billion in 2023 and is projected to reach USD 18.09 billion by 2032, expanding at a CAGR of 8.52% during the forecast period of 2024 to 2032. This robust growth is attributed to the increasing global burden of osteoarthritis, advancements in regenerative medicine, and the rising adoption of...